Cargando…

Specific immunotherapy with mugwort pollen allergoid reduce bradykinin release into the nasal fluid

INTRODUCTION: A pathomechanism of allergic rhinitis is complex. A neurogenic mechanism seems to play a significant role in this phenomenon. AIM: The evaluation of influence of specific immunotherapy of mugwort pollen allergic patients on the bradykinin concentration in the nasal lavage fluid. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gawlik, Radoslaw, Grzanka, Alicja, Jawor, Barbara, Czecior, Eugeniusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004215/ https://www.ncbi.nlm.nih.gov/pubmed/27605897 http://dx.doi.org/10.5114/ada.2016.61602

Ejemplares similares

240 Mold Sensitization in Chronic Rhinosinusitis Patients
por: Gawlik, Radoslaw, et al.
Publicado: (2012)

Frequency of IgE-dependent hypersensitivity to moulds in patients with chronic rhinosinusitis with polyps
por: Gawlik, Radosław, et al.
Publicado: (2014)

Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
por: Bożek, Andrzej, et al.
Publicado: (2017)

A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy
por: Bilancia, Massimo, et al.
Publicado: (2020)

Antigenic relationship between mugwort and ragweed pollens by crossed immunoelectrophoresis.
por: Park, H. S., et al.
Publicado: (1994)

Standardization of Weed Pollen Extracts, Japanese Hop and Mugwort, in Korea
por: Jeong, Kyoung Yong, et al.
Publicado: (2016)

Immunoelectron-microscopic localization of IgE binding site of mugwort pollen.
por: Park, H. S., et al.
Publicado: (1993)

Poster 1000: Efficacy and safety of specific sublingual immunotherapy with carbamylated allergoid tablets of ragweed pollen: a dose-ranging study
por: Compalati, Enrico, et al.
Publicado: (2014)

Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background
por: Knapp, Bernhard, et al.
Publicado: (2012)

11 Efficacy and Tolerability of HDM Injective Immunotherapy With Monomeric Allergoid
por: Compalati, Enrico, et al.
Publicado: (2012)

Clinical utility of basophil activation test in diagnosis and predicting severity of mugwort pollen-related peach allergy
por: Deng, Shan, et al.
Publicado: (2019)

Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis
por: Shershakova, Nadezda, et al.
Publicado: (2015)

T-cell subset changes during the first year of pre-seasonal allergoid allergen-specific immunotherapy
por: Reithofer, Manuel, et al.
Publicado: (2023)

A meta‐analysis on allergen‐specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)‐adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis
por: Becker, Sven, et al.
Publicado: (2021)

The relative clinical impact of sublingual immunotherapy with carbamylated monomeric allergoids on allergic respiratory symptoms
por: Compalati, Enrico, et al.
Publicado: (2015)

Intradermal Phleum pratense allergoid immunotherapy. Double‐blind, randomized, placebo‐controlled trial
por: Sola Martínez, Francisco Javier, et al.
Publicado: (2020)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

Seasonal variation in circulating group 2 innate lymphoid cells in mugwort-allergic asthmatics during and outside pollen season
por: Miao, Qing, et al.
Publicado: (2018)

Selective Inhibition of Wild Sunflower Reproduction with Mugwort Aqueous Extract, Tested on Cytosolic Ca(2+) and Germination of the Pollen Grains
por: Del Pino, Alberto Marco, et al.
Publicado: (2021)

A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy
por: Roger, Albert, et al.
Publicado: (2014)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy
por: Worm, M., et al.
Publicado: (2018)

Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy
por: Starchenka, Sviatlana, et al.
Publicado: (2019)

First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy
por: Nieto, Antonio, et al.
Publicado: (2022)

Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2‐year double‐blind, placebo‐controlled, randomized trial plus 1‐year open‐label extension
por: Worm, Margitta, et al.
Publicado: (2019)

Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis
por: Kim, Sae-Hoon, et al.
Publicado: (2018)

Efficacy of indoor air purification in treating Artemisia (mugwort) pollen allergic rhinitis: study protocol for a randomised controlled trial
por: Chen, Qiao-yan, et al.
Publicado: (2018)

Mugwort Pollen-Related Food Allergy: Lipid Transfer Protein Sensitization and Correlation With the Severity of Allergic Reactions in a Chinese Population
por: Deng, Shan, et al.
Publicado: (2018)

98 Specific IGE and IGG Binding to Allergoids of Phleum pratense
por: Cases, Barbara, et al.
Publicado: (2012)

An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial
por: Chaker, A. M., et al.
Publicado: (2016)

Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis
por: Jura-Szołtys, Edyta, et al.
Publicado: (2022)

Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps
por: Plewka, Danuta, et al.
Publicado: (2017)

Expression of the major mugwort pollen allergen Art v 1 in tobacco plants and cell cultures: problems and perspectives for allergen production in plants
por: Siegert, Marc, et al.
Publicado: (2011)

484 Allergen Standardisation in Allergens and Allergoids—Challenges and Considerations
por: Skinner, Murray, et al.
Publicado: (2012)

Mugwort-Mustard Allergy Syndrome due to Broccoli Consumption
por: Sugita, Yuri, et al.
Publicado: (2016)

Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany
por: Verheggen, Bram G, et al.
Publicado: (2015)

Peripheral effector memory regulatory T cells are incremented and functionally enhanced in successful mite monomeric allergoid sublingual immunotherapy
por: Petrarca, Claudia, et al.
Publicado: (2020)

Major Grass Pollen Allergen Components and Cross-Reactive Carbohydrate Determinants in Mugwort-Sensitized Child Patients With Allergic Respiratory Disease in Western China
por: Liao, Chenxi, et al.
Publicado: (2022)

Novel vaccines targeting dendritic cells by coupling allergoids to mannan
por: Benito-Villalvilla, Cristina, et al.
Publicado: (2018)

Bradykinin Release Avoids High Molecular Weight Kininogen Endocytosis
por: Damasceno, Igor Z., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ghv6nihsrqqmdqm14pq700gcp3